Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Morgan Stanley (MS) Going to Burn These Hedge Funds?

Hedge funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Insider Monkey, we follow over 700 of the best-performing investors and by analyzing their 13F filings, we can determine the stocks that they are collectively bullish on. One of their picks is Morgan Stanley (NYSE:MS), one of the 10 Most Ruthless Companies in Business Today, so let’s take a closer look at the sentiment that surrounds it in the current quarter.

Morgan Stanley (NYSE:MS) was owned by 51 hedge funds at the end of the third quarter, remaining within a narrow range of hedge fund ownership for the fifth-straight quarter. Morgan Stanley topped our list of the 20 Dividend Stocks That Billionaires Are Piling On, though it nonetheless failed to finish among the 30 Most Popular Stocks Among Hedge Funds. Even with its dividend yield approaching 3%, Morgan Stanley’s payout ratio is well under control at less than 25%.

In the eyes of most market participants, hedge funds are perceived as underperforming, old investment tools of years past. While there are over 8,000 funds in operation today, our experts choose to focus on the crème de la crème of this group, about 700 funds. These investment experts direct the majority of the hedge fund industry’s total asset base, and by tailing their top stock picks, Insider Monkey has come up with various investment strategies that have historically surpassed the market. Insider Monkey’s flagship hedge fund strategy outstripped the S&P 500 index by 6 percentage points a year since its inception in May 2014 through early November 2018. We were able to generate large returns even by identifying short candidates. Our portfolio of short stocks lost 26.1% since February 2017 even though the market was up nearly 19% during the same period. We just shared a list of 11 short targets in our latest quarterly update.

VALUEACT CAPITAL

How have hedgies been trading Morgan Stanley (NYSE:MS)?

At the end of the third quarter, a total of 51 of the hedge funds tracked by Insider Monkey held long positions in this stock, a 4% rise from the previous quarter. The graph below displays the number of hedge funds with bullish position in MS over the last 13 quarters. So, let’s check out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

MS_nov2018

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, ValueAct Capital, managed by Jeffrey Ubben, holds the biggest position in Morgan Stanley (NYSE:MS). ValueAct Capital has a $969.1 million position in the stock, comprising 9.5% of its 13F portfolio. The second most bullish fund manager is Ken Griffin of Citadel Investment Group, with a $919.6 million position; 0.4% of its 13F portfolio is allocated to the stock. Other peers that hold long positions include Boykin Curry’s Eagle Capital Management, Richard S. Pzena’s Pzena Investment Management and Noam Gottesman’s GLG Partners.

As one would reasonably expect, key money managers were leading the bulls’ herd. Masters Capital Management, managed by Mike Masters, initiated the most valuable call position in Morgan Stanley (NYSE:MS). Masters Capital Management had $46.6 million invested in the company at the end of the quarter. Dmitry Balyasny’s Balyasny Asset Management also initiated a $44.1 million position during the quarter. The following funds were also among the new MS investors: Jason Karp’s Tourbillon Capital Partners, Kevin D. Eng’s Columbus Hill Capital Management, and Paul Marshall and Ian Wace’s Marshall Wace LLP.

Let’s go over hedge fund activity in other stocks – not necessarily in the same industry as Morgan Stanley (NYSE:MS) but similarly valued. These stocks are Banco Santander, S.A. (NYSE:SAN), ASML Holding N.V. (NASDAQ:ASML), CVS Health Corporation (NYSE:CVS), and Baidu, Inc. (NASDAQ:BIDU). This group of stocks’ market valuations resemble MS’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
SAN 19 754414 -1
ASML 13 525470 1
CVS 49 1926232 2
BIDU 53 4052257 -14

View table here if you experience formatting issues.

As you can see these stocks had an average of 34 hedge funds with bullish positions and the average amount invested in these stocks was $1.82 billion. That figure was $4.64 billion in MS’s case. Baidu, Inc. (NASDAQ:BIDU) is the most popular stock in this table. On the other hand ASML Holding N.V. (NASDAQ:ASML) is the least popular one with only 13 bullish hedge fund positions. Morgan Stanley (NYSE:MS) is not the most popular stock in this group but hedge fund interest is still above average. This is a positive signal and Morgan Stanley is particularly popular among the wealthiest investors. This looks like a good dividend stock to hold for the long term.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...